## ALGN: Align Technology, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.93 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($152.43)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. Who Owns Align Technology? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260105T150744 | Neutral | Relevance: 100%
- This article examines the top shareholders and recent insider trades of Align Technology, Inc. (NASDAQ: ALGN), a company specializing in clear aligner systems and dental tools. It highlights that major institutional investors like The Vanguard Group and BlackRock maintain significant stakes, while active managers and hedge funds show mixed but increasingly selective positioning. Insider trades are generally small and administrative, indicating cautious long-term interest rather than aggressive moves by executives.

**2. Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)**
- Source: Simply Wall Street | 20260104T121451 | Bullish | Relevance: 100%
- Align Technology (NASDAQ:ALGN) has demonstrated encouraging trends in its Return on Capital Employed (ROCE), which has substantially increased to 15% over the last five years, outperforming the Medical Equipment industry average of 11%. This indicates the company is effectively reinvesting profits to generate higher returns, despite a significant stock price decline over the same period. For investors, it suggests a business efficiently utilizing capital, warranting further research into its future prospects and intrinsic value.

**3. A fabricante do Invisalign, Align Technology, corta a previsão de receita anual devido à fraca demanda**
- Source: TradingView – Acompanhe todos os mercados | 20260103T130747 | Bearish | Relevance: 100%
- Align Technology (ALGN), fabricante do Invisalign, reduziu sua previsão de crescimento anual de receita para 2025 devido à incerteza macroeconômica e à fraca demanda por seus produtos odontológicos, causando uma queda de 30% nas ações. A empresa agora espera um crescimento estável ou ligeiramente superior a 2024, em contraste com a previsão anterior de 3,5% a 5,5%. Além disso, a Align Technology planeja reestruturar grupos de negócios, reduzir sua força de trabalho global e otimizar a produção, com encargos únicos estimados entre US$ 150 milhões e US$ 170 milhões no segundo semestre de 2025.

**4. Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)**
- Source: Simply Wall Street | 20260104T120728 | Bullish | Relevance: 96%
- Align Technology (NASDAQ:ALGN) is showing encouraging signs with its Return on Capital Employed (ROCE), which has increased substantially over the last five years to 15%. This indicates that the company is effectively making more money per dollar of capital used, even as its capital has also grown by 30%. While the stock has seen a significant decline over the past five years, the improving ROCE suggests the company is efficiently reinvesting profits for higher returns.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $170 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (+0.7%)
- Blackrock Inc.: 6.9% (-3.4%)
- Ninety One UK Ltd: 6.3% (+136.6%)
- Capital Internationa: 4.2% (+88.6%)
- State Street Corpora: 4.0% (-1.3%)

### Key Risks

1. High beta (1.83) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.6B |
| Beta | 1.83 |
| 52W Range | $122.00 - $237.23 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 14.6 |
| Current P/E | 15.7 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.9% to 0.1% (+1.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-1.07), momentum weakening. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.13% (CS: 43) | Neutral |
| RSI_14 | 60.4 | Neutral |
| MACD Histogram | -1.07 | Bearish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.083x | Above |
| vs SMA200 | 1.007x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $160.13
- **Stop Loss:** $152.43 (4.8% risk)
- **Target:** $175.53 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 112
- **Position Value:** $17,934.56
- **Portfolio %:** 17.93%
- **Risk Dollars:** $862.50
- **Risk Per Trade:** 0.86%
- **Modifiers:** L1 115% | L2 75% | Combined 0.86x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-04 (Est: $2.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.41 | $2.61 | +8.4% |
| 2025Q2 | $2.57 | $2.49 | -3.3% |
| 2025Q1 | $1.99 | $2.13 | +7.1% |
| 2024Q4 | $2.45 | $2.44 | -0.4% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*